Congress

AACR 2022

Annual Meeting

Secure your spot

April 11-12 2022

Booth #1806

New Orleans USA

Lunaphore at AACR 2022

Discover the only high-throughput hyperplex solution at AACR 2022

Join us at the AACR 2022 Annual Meeting at booth #1806 and discover the only spatial biology solutions which do not require any upstream conjugation or barcoding. Learn how to minimize validation challenges. Get more data faster.

Follow our exclusive presentations featured at our dinner reception and exhibitor spotlight theatre. Meet our scientists on-site to discover new ways of utilizing standard reagents to perform high-plex immunofluorescence assays, empowering your lab with a fast and reliable slide-in data-out approach.

Lunaphore has re-engineered multiplex IHC on tissue samples, not dictated by reagents. Our hyperplex solution, COMET™, works with any non-conjugated primary antibody you already know. The system is powered by a patented chip technology to extract proteomic data from tissue samples while keeping it in a morphological context.

  • All-in-one, hyperplex IF solution for all labs                                                                                                                                            End-to-end automation of multiplex immunofluorescence staining and imaging with simple and efficient assay optimization guidance.
  • Multiplex with standard, non-conjugated antibodies                                                                                                                         Use your tissue samples as you already use them while working with your standard antibody libraries; no conjugation or barcoding is needed.
  • More data, faster                                                                                                                                                                                                 Set up a new multiplex assay in days and start generating complete immunofluorescence data sets of up to 40-plex on a daily base for four samples in parallel.

“Hyperplex spatial biology made easy.”

Listen to world-class scientists. Check data. Talk with users.

The dinner reception, sponsored by Lunaphore and Affiliated with the AACR 2022 Annual Meeting, brings together world-class scientific experts from the industry and academic research institutions. By attending the event, you will discover how Lunaphore’s solutions streamline single-cell hyperplex assays and allow move seamlessly from discovery to translational research. You will have the chance to hear from users presenting their experience with the novel COMET™ system, including operation, performance, and panel development.

After that, we will welcome on stage the guest speakers: Dr. Michael Surace, Prof. Dr. MD Janis Taube, and Dr. MD Carlo Bifulco. They will be engaged in a roundtable discussion: “Multiplex immunofluorescence in cancer biology.”

Please note: 

Participation of Dr. Taube, Dr. Bifulco, and Dr. Surace as guest speakers does not constitute or imply endorsement of Lunaphore by John Hopkins University, Providence, and AstraZeneca.

April 11, 2022

Afiliate dinner reception

6:30 - 11:59 PM CTS

Renaissance New Orleans Arts Hotel, 700 Tchoupitoulas St., New Orleans, LA 7013

Reception and cocktails

6:30 – 7:00 PM CST

Opening remarks

7:00 – 7:10 PM CST
Deborah Heintze – Chief Marketing Officer, Lunaphore

Technology & hyperplex solutions

7:10 – 7:30 PM CST
Dr. Diego Dupouy – Chief Technology Officer, Lunaphore

User Experience in Design, Operation, and Validation of a 21-Marker Panel on the Lunaphore COMET™

7:30 – 8:00 PM CST
Dr. Michael Surace – Associate Director, AstraZeneca, USA

Learning points

  • COMET™ technology walkthrough + mIF landscape
  • What a multiplex validation should cover
  • COMET™ validation plan
  • What worked & lessons learned
Roundtable discussion – mIF in cancer biology

8:00 – 8:30 PM CST
GUEST SPEAKERS
Dr. Janis Taube, M.D., M.Sc. – Director of the Dermatopathology division, The Johns Hopkins Hospital

Dr. Michael Surace – Associate Director, AstraZeneca, USA

Dr. Carlo Bifulco, M.D. – Director of Translational Molecular Pathology and Molecular Genomics, Providence Cancer Institute.

Discussion points:

  • mIF panel validation: status and outlooks
  • User experience: ideal requirements of a technological platform
  • Off-the-shelf and openness of reagents: a tangible asset or a dangerous entropic approach?
Closing remarks & technology adoption opportunities

8:30 – 8:40 PM CST
Everton Robinson – VP Sales and Customer Support, Lunaphore

Networking

8:40 – 11:59 PM CST

April 11, 2022

Poster Presentation

1:30 – 5:00 PM CST

Poster Section 15

Mapping the cellular architecture of the tumor microenvironment by integrating hyperplex immunofluorescence and automated image analysis

April 12, 2022

Exhibitor Spotlight Theater

10:00 AM CST

Theater B

Book a meeting with us